SCHEMBL6027737

SCHEMBL6027737

Cc1nc2c(Cl)nccc2n1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.48
CYP3A4 P08684 2/20 0.48
CYP2C9 P11712 2/20 0.48
CYP2C19 P33261 2/20 0.48
RXFP1 Q9HBX9 1/20 0.44
RPS6KA5 O75582 2/20 0.42
ADORA2A P29274 1/20 0.39
ADORA2B P29275 1/20 0.39
ADORA1 P30542 1/20 0.39
CYP2D6 P10635 1/20 0.38
KDM4E B2RXH2 2/20 0.37
LMNA P02545 2/20 0.37
ALDH1A1 P00352 1/20 0.37
JAK2 O60674 1/20 0.35
TYK2 P29597 1/20 0.35
MAPT P10636 1/20 0.35
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
HTR6 P50406 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4468691 0.80 RXFP1 (0.42) CYP1A2CYP3A4CYP2C9CYP2C19RXFP1
SCHEMBL3790456 0.78 ADORA2A (0.63) CYP1A2CYP3A4CYP2C9CYP2C19ADORA2A
SCHEMBL4458405 0.77 ADORA2A (0.67) RXFP1RPS6KA5ADORA2AADORA2BADORA1
SCHEMBL29878888 0.76 RXFP1 (0.40) CYP1A2CYP3A4CYP2C9CYP2C19RXFP1
SCHEMBL28850551 0.76 RXFP1 (0.40) CYP1A2CYP3A4CYP2C9CYP2C19RXFP1
SCHEMBL7894650 0.76 PSEN1 (0.44) CYP3A4CYP2C9CYP2C19RXFP1RPS6KA5
SCHEMBL14685153 0.74 TLR7 (0.48) RXFP1RPS6KA5ADORA2AADORA2BADORA1
SCHEMBL24401874 0.73 KDM4E (0.39) CYP1A2CYP3A4CYP2C9CYP2C19ADORA2A
SCHEMBL4454549 0.73 NOTUM (0.40) CYP1A2CYP2C9CYP2C19RXFP1RPS6KA5
SCHEMBL3295739 0.72 CYP1A2 (0.49) CYP1A2CYP3A4CYP2C9CYP2C19CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060194782-A1 Pharmacologically active imidazo[4,5-c] pyridines ALTANA PHARMA AG (DE) 2006-08-31 US disclosed
EP-1670795-A1 PHARMACOLOGICALLY ACTIVE IMIDAZO 4,5-C PYRIDINES ALTANA Pharma AG (DE) 2006-06-21 EP disclosed
WO-2005026164-A1 PHARMACOLOGICALLY ACTIVE IMIDAZO[4,5-C]PYRIDINES ALTANA PHARMA AG (DE) 2005-03-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060194782-A1 Pharmacologically active imidazo[4,5-c] pyridines GIPR, VIP, PGC CYP1A2 216/4885CYP3A4 29/4885CYP2C9 578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.